Critical Jh Syngeneic Tumor Model Host Now Available on a B6 Background Rensselaer, NY — January 18, 2021 - Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces an expansion of its immuno-oncology portfolio. Immuno-oncology is a leading research priority because it uses the body's own immune system to effectively treat some types of cancer. Syngeneic tumor animal models play a critical role... Read More